A medical device company based in Morrisville, North Carolina, wants to raise $950,000 from warrants and options, according to a filing Friday with the Securities and Exchange Commission.

TransEnterix Inc. is a medical device company that uses robotics to improve and facilitate minimally invasive surgery.

The company is focused on the commercialization of the Senhance Surgical Robotic System, a multi-port robotic system that brings the advantages and benefits of robotic surgery to patients while enabling surgeons with innovative technology, such as haptic feedback and eye-sensing camera control.

In August, TransEnterix announced that it installed a Senhance Surgical Robot at the Institute for Surgical Advancement at Florida Hospital Orlando.

“The selection of a U.S. innovation center is a critical milestone in the global expansion of Senhance,” said TransEnterix Chief Executive Officer Todd M. Pope in a statement. “We are pleased to partner with a leading institution such as Florida Hospital Orlando and the clinicians at the Institute for Surgical Advancement.”

The Institute for Surgical Advancement is the first U.S. center to explore the new surgical robotic platform. TransEnterix, founded in 2006, now has Senhance systems in hospitals in France, Germany, Italy, Japan, the United Kingdom and the United States.

TransEnterix also developed the SurgiBot System, a robotically enhanced laparoscopic surgical platform.

According to the filing, the offering is not made in connection with a merger, acquisition or exchange.

TransEnterix stock closed Friday at $1.48 per share, up 5 cents.

Companies relying on a Reg D exemption do not have to register their offering of securities with the SEC, but they must file what’s known as a Form D electronically with the SEC after they first sell their securities.